Mujtaba H Mohammad1, Emmanuel Chavredakis1, Rasheed Zakaria1,2, Andrew Brodbelt1, Michael D Jenkinson1,3. 1. a Department of Neurosurgery , The Walton Centre NHS Foundation Trust , Liverpool , UK. 2. b Institute of Integrative Biology, University of Liverpool , Liverpool , UK. 3. c Institute of Translational Medicine, University of Liverpool , Liverpool , UK.
Abstract
BACKGROUND: Incidental meningiomas are increasingly being diagnosed due to widespread use of brain imaging. Treatment options include surveillance, surgery and stereotactic radiosurgery, but the natural history of these tumours is not fully understood and there are no accepted management guidelines to aid clinical decision-making. The aim of this study was to assess current practice in the United Kingdom and identify areas of variation for further study. METHODS: A questionnaire was distributed to all members of the Society of British Neurosurgeons (SBNS). The main components of the survey included the assessment of which factors and tumour characteristics are considered in the management and follow-up of incidental meningiomas. Two case scenarios were also presented. RESULTS: The response rate was 12.5% (44 completed surveys) with 74% (25/34) of neurosurgical centres represented. Absence of calcification was only considered by 36% (16/44) of neurosurgeons. Most neurosurgeons opt for surveillance at initial presentation, and the length of follow-up was 5 years (14/33) and 10 years (11/33). The case scenarios highlighted that tumour growth at follow-up resulted in a preference to change from surveillance to treatment with surgery or SRS. SRS was preferred in skull-base (23/36) and medial sphenoid wing (16/39) tumours. CONCLUSIONS: This survey has demonstrated that certain aspects of incidental meningioma management show variation and remain controversial. Further research through prospective cohort studies is required to provide evidence to support guidelines for the management of incidental meningiomas.
BACKGROUND: Incidental meningiomas are increasingly being diagnosed due to widespread use of brain imaging. Treatment options include surveillance, surgery and stereotactic radiosurgery, but the natural history of these tumours is not fully understood and there are no accepted management guidelines to aid clinical decision-making. The aim of this study was to assess current practice in the United Kingdom and identify areas of variation for further study. METHODS: A questionnaire was distributed to all members of the Society of British Neurosurgeons (SBNS). The main components of the survey included the assessment of which factors and tumour characteristics are considered in the management and follow-up of incidental meningiomas. Two case scenarios were also presented. RESULTS: The response rate was 12.5% (44 completed surveys) with 74% (25/34) of neurosurgical centres represented. Absence of calcification was only considered by 36% (16/44) of neurosurgeons. Most neurosurgeons opt for surveillance at initial presentation, and the length of follow-up was 5 years (14/33) and 10 years (11/33). The case scenarios highlighted that tumour growth at follow-up resulted in a preference to change from surveillance to treatment with surgery or SRS. SRS was preferred in skull-base (23/36) and medial sphenoid wing (16/39) tumours. CONCLUSIONS: This survey has demonstrated that certain aspects of incidental meningioma management show variation and remain controversial. Further research through prospective cohort studies is required to provide evidence to support guidelines for the management of incidental meningiomas.
Authors: Yasir A Chowdhury; Andrew R Stevens; Wai C Soon; Emma Toman; Tonny Veenith; Ramesh Chelvarajah; Antonio Belli; David Davies Journal: Cureus Date: 2022-06-12
Authors: Christopher P Millward; Terri S Armstrong; Heather Barrington; Sabrina Bell; Andrew R Brodbelt; Helen Bulbeck; Anna Crofton; Linda Dirven; Theo Georgious; Paul L Grundy; Abdurrahman I Islim; Mohsen Javadpour; Sumirat M Keshwara; Shelli D Koszdin; Anthony G Marson; Michael W McDermott; Torstein R Meling; Kathy Oliver; Puneet Plaha; Matthias Preusser; Thomas Santarius; Nisaharan Srikandarajah; Martin J B Taphoorn; Carole Turner; Colin Watts; Michael Weller; Paula R Williamson; Gelareh Zadeh; Amir H Zamanipoor Najafabadi; Michael D Jenkinson Journal: BMJ Open Date: 2022-05-09 Impact factor: 3.006
Authors: Charles Lane Anzalone; Amy Glasgow; Elizabeth Habermann; Brandon R Grossard; Jamie J Van Gompel; Matthew L Carlson Journal: J Neurol Surg B Skull Base Date: 2018-12-26
Authors: Abdurrahman I Islim; Ruwanthi Kolamunnage-Dona; Midhun Mohan; Richard D C Moon; Anna Crofton; Brian J Haylock; Nitika Rathi; Andrew R Brodbelt; Samantha J Mills; Michael D Jenkinson Journal: Neuro Oncol Date: 2020-02-20 Impact factor: 12.300